Shaji Kumar, MD
Mayo Clinic · Mayo
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Shaji Kumar, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:32 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT07285239 · Belantamab Mafodotin or Daratumumab With Bortezomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multiple MyelomaPrECOG, LLC. · recruiting · Multiple Myeloma · study chair
- Ph1/Ph2NCT03915184 · Clinical Trial to Evaluate Zevor-cel (CT053) in Patients With Relapsed and/or Refractory Multiple Myeloma (LUMMICAR STUDY 2)CARsgen Therapeutics Co., Ltd. · active not recruiting · Multiple Myeloma · principal investigator
- Ph2NCT03289299 · Aggressive Smoldering Curative Approach Evaluating Novel Therapies and TransplantInternational Myeloma Foundation · active not recruiting · Smoldering Multiple Myeloma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:32 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in multiple myeloma.